ea0035p534 | Endocrine tumours and neoplasia | ECE2014
Marciello Francesca
, Modica Roberta
, Marotta Vincenzo
, Ramundo Valeria
, Prete Michela Del
, Buonomano Pasqualina
, Carratu Anna Chiara
, de Luca di Roseto Chiara
, Picillo Ester
, Colao Annamaria
, Faggiano Antongiulio
Introduction: Recent data suggest that metformin has antineoplastic properties in different type of cancer. Effects of metformin have never been investigated in neuroendocrine tumors (NET).We aim to determine the role of metformine on recurrence-free survival (RFS) in NET patients.Materials and methods: A retrospective analysis was conducted comparing NET patients with recent diagnosis (<3 year) of diabetes mellitus (with HbA1c...